Flawless 1ml × 2 — CE Certified Korean HA Filler with Patented Multi-Layered Phasic Technology

Flawless is a CE-marked Korean cross-linked hyaluronic acid dermal filler manufactured by QUIVER MEDIC, Corp. in Seoul, South Korea. Each pack contains 2 × 1 mL prefilled syringes with 20 mg/mL HA and 3 mg/mL lidocaine. The product is built on the world’s first patented Multi-layered Phasic technology — a structure combining biphasic HA particles with monophasic HA gel — and is available in three variants: Fine, Deep, and Sub Q.

Multi-layered Phasic is the world’s first patented structure where biphasic HA particles and monophasic HA gel coexist in a single formulation. The HA particles provide lifting and holding force; the monophasic gel buffers the high-recovery particles from direct contact with the treatment area, reducing the unnatural feel that can occur with pure biphasic fillers. The combined structure is designed to deliver projection plus smooth tissue integration.

All three share 20 mg/mL HA and 3 mg/mL lidocaine but differ in particle size and intended injection depth. Flawless Fine targets superficial and mid dermis (fine lines, tear troughs) with 3–6 month duration. Flawless Deep covers mid-to-deep dermis (nasolabial folds, cheek volume) with 6–12 month duration. Flawless Sub Q is the thickest variant for subcutaneous and supraperiosteal placement (chin, jawline, temples) with duration over 12 months.

Yes. Flawless is CE marked — confirming the product meets the European Union safety, health, and environmental requirements for medical devices. CE marking covers all three variants (Fine, Deep, Sub Q) and qualifies the product for distribution in jurisdictions that recognise the CE mark, including the European and UK aesthetic markets.

VAS stands for Visual Analogue Scale — a standard clinical tool to measure pain intensity. A VAS Score of 3.0 is the conventional threshold for “Not painful.” Flawless documents a VAS Score of 2.3, indicating low procedural discomfort — below the “not painful” threshold. The combination of the patented Multi-layered Phasic structure and 3 mg/mL premixed lidocaine contributes to this profile.

Flawless is manufactured by QUIVER MEDIC, Corp., a Korean medical device company headquartered in Seoul, South Korea. The official product website is . Manufacturing follows Korean medical device quality system requirements, and CE marking covers distribution in the European and UK aesthetic markets.

Yes. Flawless is a cross-linked hyaluronic acid filler and is fully reversible with hyaluronidase enzyme dissolution — the standard correction approach for HA fillers. The Multi-layered Phasic structure does not interfere with hyaluronidase activity, allowing quick reversal of placement if clinically indicated. Hyaluronidase should always be stocked at the clinic before HA filler treatment.

Duration varies by variant and treatment site. Flawless Fine typically lasts 3–6 months. Flawless Deep delivers 6–12 months. Flawless Sub Q is the longest-lasting at over 12 months due to higher viscosity and deeper placement. Actual duration depends on individual metabolism, facial movement intensity, dose, and injection technique.

Yes. Flawless Fine, Deep, and Sub Q can be layered across different anatomical zones in one session. A common approach uses Flawless Sub Q for deep contour zones (jawline, chin, temples), Flawless Deep for mid-face volume, and Flawless Fine for superficial smoothing. Because all three share the same HA chemistry and Multi-layered Phasic technology, layered biocompatibility is consistent.

No. Flawless uses non-animal hyaluronic acid produced by bacterial fermentation — the standard manufacturing approach for modern HA dermal fillers. The product contains no animal proteins or by-products, making it suitable for patients who avoid animal-derived medical products.